Product Information
DEXILANT DR 60 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.8408 per EA under NDC 64764017530. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexlansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764017530
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA022287FDA Approved
1/30/2009
TE Code
AB
On Market Since
4/12/2010
Pharmacological Classes
Price Statistics
The NADAC for DEXILANT DR 60 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8408 per EA |
|---|---|
| All-time high | $9.8740 (Oct 13, 2021) |
| All-time low | $5.4847 (Nov 28, 2013) |
| 52-week high | $9.8562 |
| 52-week low | $9.8408 |
| Median price | $9.3040 |
| Average price | $8.7729 |
| Largest weekly change | +9.9% (Jun 10, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXILANT DR 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DEXILANT DR 60 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $9.8408 per EA (NDC 64764017530), effective Aug 19, 2026.
How has the price of DEXILANT DR 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DEXILANT DR 60 MG CAPSULE has risen 79.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXILANT DR 60 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DEXILANT DR 60 MG CAPSULE has ranged from a low of $5.4847 (Nov 28, 2013) to a high of $9.8740 (Oct 13, 2021), with a median of $9.3040 per EA.
Are there cheaper alternatives to DEXILANT DR 60 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXLANSOPRAZOLE DR 60 MG CAP, is $3.6568 per EA — about 63% below DEXILANT DR 60 MG CAPSULE.
Who manufactures DEXILANT DR 60 MG CAPSULE?
DEXILANT DR 60 MG CAPSULE (NDC 64764017530) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.